RIPK1 is required for ZBP1-driven necroptosis in human cells

被引:0
|
作者
Amusan, Oluwamuyiwa T. [1 ]
Wang, Shuqi [1 ]
Yin, Chaoran [2 ]
Koehler, Heather S. [3 ]
Li, Yixun [1 ]
Tenev, Tencho [4 ]
Wilson, Rebecca [4 ]
Bellenie, Benjamin [5 ]
Zhang, Ting [2 ]
Wang, Jian [1 ,6 ]
Liu, Chang [7 ]
Seong, Kim [1 ]
Poorbaghi, Seyedeh L. [1 ]
Yates, Joseph [1 ]
Shen, Yuchen [1 ]
Upton, Jason W. [8 ]
Meier, Pascal [4 ]
Balachandran, Siddharth [2 ]
Guo, Hongyan [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Microbiol & Immunol, Shreveport, LA 70802 USA
[2] Fox Chase Canc Ctr, Blood Cell Dev & Funct, Philadelphia, PA USA
[3] Washington State Univ, Sch Mol Biosci, Pullman, WA USA
[4] Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, London, England
[5] Ctr Canc Drug Discovery, Inst Canc Res, London, England
[6] Louisiana State Univ, Ctr Appl Immunol & Pathol Proc, Hlth Sci Ctr Shreveport, Shreveport, LA USA
[7] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD USA
[8] Auburn Univ, Dept Biol Sci, Auburn, AL USA
关键词
MIXED LINEAGE KINASE; PROGRAMMED NECROSIS; DOMAIN-LIKE; PROTEIN; BINDING; RNA; INNATE; PHOSPHORYLATION; MACROPHAGES; DOWNSTREAM;
D O I
10.1371/journal.pbio.3002845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Necroptosis initiated by the host sensor Z-NA binding protein 1 (ZBP1) is essential for host defense against a growing number of viruses, including herpes simplex virus 1 (HSV-1). Studies with HSV-1 and other necroptogenic stimuli in murine settings have suggested that ZBP1 triggers necroptosis by directly complexing with the kinase RIPK3. Whether this is also the case in human cells, or whether additional co-factors are needed for ZBP1-mediated necroptosis, is unclear. Here, we show that ZBP1-induced necroptosis in human cells requires RIPK1. We have found that RIPK1 is essential for forming a stable and functional ZBP1-RIPK3 complex in human cells, but is dispensable for the formation of the equivalent murine complex. The receptor-interacting protein (RIP) homology interaction motif (RHIM) in RIPK3 is responsible for this difference between the 2 species, because replacing the RHIM in human RIPK3 with the RHIM from murine RIPK3 is sufficient to overcome the requirement for RIPK1 in human cells. These observations describe a critical mechanistic difference between mice and humans in how ZBP1 engages in necroptosis, with important implications for treating human diseases.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Inhibition of Necroptosis in Acute Pancreatitis: Screening for RIPK1 Inhibitors
    Yao, Jiaqi
    Luo, Yalan
    Liu, Xiaojun
    Wu, Ping
    Wang, Yin
    Liu, Yan
    Chen, Hailong
    Wen, Qingping
    PROCESSES, 2022, 10 (11)
  • [22] RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis
    Orozco, S.
    Yatim, N.
    Werner, M. R.
    Tran, H.
    Gunja, S. Y.
    Tait, S. W. G.
    Albert, M. L.
    Green, D. R.
    Oberst, A.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (10): : 1511 - 1521
  • [23] RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis
    S Orozco
    N Yatim
    M R Werner
    H Tran
    S Y Gunja
    S WG Tait
    M L Albert
    D R Green
    A Oberst
    Cell Death & Differentiation, 2014, 21 : 1511 - 1521
  • [24] O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
    Seo, Junghwa
    Kim, Yeolhoe
    Ji, Suena
    Kim, Han Byeol
    Jung, Hyeryeon
    Yi, Eugene C.
    Lee, Yong-ho
    Shin, Injae
    Yang, Won Ho
    Cho, Jin Won
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
    Wegner, Kelby W.
    Saleh, Danish
    Degterev, Alexei
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (03) : 202 - 225
  • [26] RIPK1 protects epithelial cells
    Kim Baumann
    Nature Reviews Molecular Cell Biology, 2014, 15 : 629 - 629
  • [27] TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
    Jouan-Lanhouet, S.
    Arshad, M. I.
    Piquet-Pellorce, C.
    Martin-Chouly, C.
    Le Moigne-Muller, G.
    Van Herreweghe, F.
    Takahashi, N.
    Sergent, O.
    Lagadic-Gossmann, D.
    Vandenabeele, P.
    Samson, M.
    Dimanche-Boitrel, M-T
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (12): : 2003 - 2014
  • [28] Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
    Sun, Mayu
    Ma, Xueqi
    Mu, Wei
    Li, Haonan
    Zhao, Xiaoming
    Zhu, Tengfei
    Li, Jingquan
    Yang, Yongliang
    Zhang, Haibing
    Ba, Qian
    Wang, Hui
    CELL DEATH & DISEASE, 2023, 14 (08)
  • [29] RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
    Bai, Yinliang
    Qiao, Yujun
    Li, Mingming
    Yang, Wenzhen
    Chen, Haile
    Wu, Yanqing
    Zhang, Honghua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265
  • [30] Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
    Mayu Sun
    Xueqi Ma
    Wei Mu
    Haonan Li
    Xiaoming Zhao
    Tengfei Zhu
    Jingquan Li
    Yongliang Yang
    Haibing Zhang
    Qian Ba
    Hui Wang
    Cell Death & Disease, 14